ArticleNeuro-oncology2024
Immunotherapy drives mesenchymal tumor cell state shift and TME immune response in glioblastoma patients.
Josephine D Hendriksen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it